Liquid chromatographic determination of fexofenadine in human plasma with fluorescence detection
- 29 June 2004
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 35 (4) , 937-942
- https://doi.org/10.1016/j.jpba.2004.02.036
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Role of P-Glycoprotein in PharmacokineticsClinical Pharmacokinetics, 2003
- Pharmacogenomics of organic anion-transporting polypeptides (OATP)Advanced Drug Delivery Reviews, 2002
- Fruit juices inhibit organic anion transporting polypeptide–mediated drug uptake to decrease the oral availability of fexofenadineClinical Pharmacology & Therapeutics, 2002
- Determination of fexofenadine in human plasma and urine by liquid chromatography–mass spectrometryJournal of Chromatography B, 2002
- Uptake and efflux of the peptidic delta-opioid receptor agonist [D-penicillamine2,5]-enkephalin at the murine blood–brain barrier by in situ perfusionNeuroscience Letters, 2001
- The effect of rifampin administration on the disposition of fexofenadineClinical Pharmacology & Therapeutics, 2001
- FexofenadineDrugs, 2000
- Clinical Pharmacology of New Histamiine H1 Receptor AntagonistsClinical Pharmacokinetics, 1999
- A Sensitive HPLC Method for the Determination of Terfenadine and Its Metabolite in Human PlasmaJournal of Liquid Chromatography, 1994
- Determination of terfenadine and terfenadine acid metabolite in plasma using solid-phase extraction and high-performance liquid chromatography with fluorescence detectionJournal of Chromatography B: Biomedical Sciences and Applications, 1991